Carmat 주식 가격. ALCAR - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

가격

0.972

매수가

0.971

매도가

0.979

거래량

366,667

0.934 일간 변동폭 0.994

0.693 52주 범위 4.42

market_cap

28.31M

전일 종가

0.93

개장가

0.97

최근 거래 시간

0.972

마지막 거래 시간

20:17:42

재정 규모

VWAP

평균 볼륨(3m)

303,440

발행 주식

29,125,768

배당수익률

주가수익률

-0.53

주당순이익(EPS)

-1.85

매출

12.6M

순이익

-53.87M

섹터

Electromedical Apparatus

산업

Electromedical Apparatus

웹사이트

www.carmatsa.com

본부

Velizy-villacoublay, Yvelines, Fra

설립됨

Carmat is listed in the Electromedical Apparatus sector of the 유로넥스트 (Euronext) with ticker ALCAR. The last closing price for Carmat was 0.93 €. Over the last year, Carmat shares have traded in a share price range of 0.693 € to 4.42 €.

Carmat currently has 29,125,768 shares in issue. The market capitalisation of Carmat is 27.09 € million. Carmat has a price to earnings ratio (PE ratio) of -0.53.

CARMAT: Aeson® total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation

Up to 25% of advanced heart failure patients suffer from pulmonary hypertension Aeson® could potentially become a standard treatment for these...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0.141	16.9675090253	0.831	1.016	0.822	730474	0.89900071	DE
4	-0.1	-9.32835820896	1.072	1.14	0.693	464736	0.87160485	DE
12	-0.094	-8.81801125704	1.066	1.36	0.693	303440	0.9769783	DE
26	-1.578	-61.8823529412	2.55	2.625	0.693	202055	1.15432222	DE
52	-3.343	-77.4739281576	4.315	4.42	0.693	144466	1.73819729	DE
156	-11.128	-91.9669421488	12.1	15.59	0.693	89706	4.99230743	DE
260	-19.728	-95.3043478261	20.7	36	0.693	66331	8.38475866	DE

ALCAR - Frequently Asked Questions (FAQ)

What is the current Carmat share price?

The current share price of Carmat is 0.972 €

How many Carmat shares are in issue?

Carmat has 29,125,768 shares in issue

What is the market cap of Carmat?

The market capitalisation of Carmat is EUR 27.09M

What is the 1 year trading range for Carmat share price?

Carmat has traded in the range of 0.693 € to 4.42 € during the past year

What is the PE ratio of Carmat?

The price to earnings ratio of Carmat is -0.53

What is the cash to sales ratio of Carmat?

The cash to sales ratio of Carmat is 2.27

What is the reporting currency for Carmat?

Carmat reports financial results in EUR

What is the latest annual turnover for Carmat?

The latest annual turnover of Carmat is EUR 12.6M

What is the latest annual profit for Carmat?

The latest annual profit of Carmat is EUR -53.87M

What is the registered address of Carmat?

The registered address for Carmat is 36 AVENUE DE L'EUROPE, IMMEUBLE L'ETENDARD, ENERGY III, VELIZY-VILLACOUBLAY, YVELINES, 78140

What is the Carmat website address?

The website address for Carmat is www.carmatsa.com

Which industry sector does Carmat operate in?

Carmat operates in the ELECTROMEDICAL APPARATUS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
ALCYBCybergun	0.0002 € (100.00%)	28.4M
ALEUPEuroplasma	0.0143 € (41.58%)	32.53M
YOUNIYounited Financial SA	17.00 € (30.77%)	150
ALALOAcheterLouerFR	0.0091 € (22.97%)	6.88M
MLLOILocasystem International	13.50 € (20.54%)	2
MLSMLSmalto	0.014 € (-30.00%)	36k
ALNEVNeovacs	0.0998 € (-20.16%)	43.92k
MLSEQSequa Petroleum NV	0.008 € (-20.00%)	2.5k
ALVERVergnet	0.0005 € (-16.67%)	23.16M
ALVGVEOM Group	0.323 € (-14.10%)	39.49k
ATOAtos SE	0.0029 € (7.41%)	2.41B
BCPBanco Comercial Portugues SA	0.5408 € (1.58%)	37.93M
ALEUPEuroplasma	0.0143 € (41.58%)	32.53M
ALCYBCybergun	0.0002 € (100.00%)	28.4M
ALVERVergnet	0.0005 € (-16.67%)	23.16M

게시물을 찾을 수 없습니다

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Carmat (ALCAR)

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

Carmat 정보

ALCAR 최신 뉴스

CARMAT: Aeson® total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation

CARMAT Achieves the Milestone of 100 Implants of Its Aeson® Total Artificial Heart

CARMAT : Information relative au nombre total de droits de vote et d’actions composant le capital social

CARMAT réalise une levée de fonds d’un montant de 9,7 M€

CARMAT lance une levée de fonds d’un montant d’environ 10 M€ bénéficiant d’engagements de souscription à hauteur de 7 M€

CARMAT: 2025 Financial Calendar

CARMAT: Aeson® total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation

CARMAT franchit le cap des 100 implantations de son cœur artificiel total Aeson®

CARMAT : Information relative au nombre total de droits de vote et d’actions composant le capital social

CARMAT réalise une levée de fonds d’un montant de 9,7 M€

CARMAT Launches a €10 Million Global Offering With €7 Million in Subscription Commitments

CARMAT : Agenda financier 2025

CARMAT annonce sa participation à plusieurs conférences scientifiques et investisseurs au cours du 1er semestre 2025

CARMAT réalise un solide exercice 2024 avec 42 implantations de son cœur artificiel Aeson® et anticipe la poursuite d’une forte dynamique en 2025

ALCAR - Frequently Asked Questions (FAQ)

이동자

ALCAR Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Carmat (ALCAR) 시세

Carmat (ALCAR)

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

Carmat 정보

ALCAR 최신 뉴스

CARMAT: Aeson® total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation

CARMAT Achieves the Milestone of 100 Implants of Its Aeson® Total Artificial Heart

CARMAT : Information relative au nombre total de droits de vote et d’actions composant le capital social

CARMAT réalise une levée de fonds d’un montant de 9,7 M€

CARMAT lance une levée de fonds d’un montant d’environ 10 M€ bénéficiant d’engagements de souscription à hauteur de 7 M€

CARMAT: 2025 Financial Calendar

CARMAT: Aeson® total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation

CARMAT franchit le cap des 100 implantations de son cœur artificiel total Aeson®

CARMAT : Information relative au nombre total de droits de vote et d’actions composant le capital social

CARMAT réalise une levée de fonds d’un montant de 9,7 M€

CARMAT Launches a €10 Million Global Offering With €7 Million in Subscription Commitments

CARMAT : Agenda financier 2025

CARMAT annonce sa participation à plusieurs conférences scientifiques et investisseurs au cours du 1er semestre 2025

CARMAT réalise un solide exercice 2024 avec 42 implantations de son cœur artificiel Aeson® et anticipe la poursuite d’une forte dynamique en 2025

ALCAR - Frequently Asked Questions (FAQ)

이동자

ALCAR Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

광고 제거